Agios Pharmaceuticals, Inc. (AGIO) NASDAQ

28.41

+0.37(+1.32%)

Updated at May 09 10:08AM

Currency In USD

Valuation

Market Cap1.87B
Enterprise Value1.85B
P/E Ratio2.46
PEG Ratio-2.9
Price/Sales Ratio44.55
Price/Book Ratio1.12
Enterprise/Revenue43.86
Enterprise/EBITDA-3.71

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterMarch 31, 2025

Profitability

Profit Margin17.98
Operating Margin-11.89

Management Effectiveness

Return On Assets0.43
Return On Equity0.5

Income Statement

Revenue36.5M
Revenue/Share0.64
Gross Profit32.33M
EBITDA-425.74M
Net Income673.73M
Diluted EPS11.64

Balance Sheet

Total Cash893.38M
Total Cash/Share15.55
Total Debt52.94M
Total Debt/Equity0.04
Current Ratio18.5
Book Value Per Share25.52

Price History

52-Week Change-13.7
52-Week High62.58
52-Week Low23.42
Moving Average 50 Days29.97
Moving Average 200 Days40.03

Statistics

Average Volume682,763
Shares Outstanding57.92M
% Held by Institutions105.04

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A